Recent studies have shown that Aβ generation, amyloid pathology, electrophysiological dysfunction, and cognitive deficits become abrogated when BACE1−/− mice are bred with APP transgenic mice [45], [46]. The gene discussed is APP; the disease is Cognitive impairment.